Skip to main content
SpringerLink
Log in

Aspirin and ACE-inhibitors: for Wedding or Funeral?

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995;345(8951):669–685.

    Google Scholar 

  2. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, Karlberg BE, Wester PO, Bjorck JE. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999;353(9153):611–616.

    Google Scholar 

  3. The Studies of Left Ventricular Dysfunction Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325(5):293–302.

    Google Scholar 

  4. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet 1997:349(9068):1787–1792.

    Google Scholar 

  5. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755–1762.

    Google Scholar 

  6. Cleland JG, Bulpitt CJ, Falk RH, Findlay IN, Oakley CM, Murray G, Poole-Wilson PA, Prentice CR, Sutton GC. Is aspirin safe for patients with heart failure? Br Heart J 1995;74(3):215–219.

    Google Scholar 

  7. Teerlink JR, Massie BM. The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers. Am Heart J 1999;138 (2 Pt 1):193–197.

    Google Scholar 

  8. Riegger AJ. Hormones in heart failure-regulation and counterregulation. Eur Heart J 1991;12(suppl D):190–192.

    Google Scholar 

  9. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. Prostaglandins in severe congestive heart failure. Relation to activation of the reninangiotensin system and hyponatremia. N Engl J Med 1984;310(6):347–352.

    Google Scholar 

  10. Ferrari R, Bachetti T, Guardigli G, Ceconi C. Bradykinin and coronary artery disease. Eur Heart J 2000;2(suppl H):H14–H19.

    Google Scholar 

  11. Cleland JGF, Witte K, Thackray S. Bradykinin and ventricular function. Eur Heart J 2000;2(suppl H):H20–H29.

    Google Scholar 

  12. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231(25):232–235.

    Google Scholar 

  13. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992;20(7):1549–1555.

    Google Scholar 

  14. Weksler BB, Pett SB, Alonso D, Richter RC, Stelzer P, Subramanian V, Tack-Goldman K, Gay WA Jr. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med 1983;308(14):800–805.

    Google Scholar 

  15. Guazzi MD, Campodonico J, Celeste F, Guazzi M, Santambrogio G, Rossi M, Trabattoni D, Alimento M. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther 1998;63(1):79–86.

    Google Scholar 

  16. Lin L, Nasjletti A. Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction. Hypertension 1991;18(2):158–164.

    Google Scholar 

  17. Baur LH, Schipperheyn JJ, van der Laarse A, Souverijn JH, Frolich M, de Groot A, Voogd PJ, Vroom TF, Cats VM, Keirse MJ, Bruschke AVG. Combining salicylate and enalapril in patients with coronary artery disease and heart failure. Br Heart J 1995;73(3):227–236.

    Google Scholar 

  18. Seyedi N, Win T, Lander HM, Levi R. Bradykinin B2–receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms. Circ Res 1997;81(5):774–784.

    Google Scholar 

  19. Seyedi N, Maruyama R, Levi R. Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norepinephrine release? J Pharmacol Exp Ther 1999;290(2):656–663.

    Google Scholar 

  20. Hatta E, Maruyama R, Marshall SJ, Imamura M, Levi R. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts. J Pharmacol Exp Ther 1999;288(3):919–927.

    Google Scholar 

  21. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84(4):1589–1596.

    Google Scholar 

  22. Parratt JR. Cardioprotection by angiotensin converting enzyme inhibitors — the experimental evidence. Cardiovasc Res 1994;28(2):183–189.

    Google Scholar 

  23. Spaulding C, Charbonnier B, Cohen-Solal A, Juilliere Y, Kromer EP, Benhamda K, Cador R, Weber, S. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a doubleblind, randomized comparative trial. Circulation 1998;98(8):757–765.

    Google Scholar 

  24. Boger RH, Bode-Boger SM, Kramme P, Tsikas D, Gutzki FM, Frolich JC. Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acid. Br J Clin Pharmacol 1996;42(6):721–727.

    Google Scholar 

  25. van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1994;23(2):240–245.

    Google Scholar 

  26. Guazzi M, Pontone G, Agostoni P. Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors. Am Heart J 1999;138 (2 Pt 1):254–260.

    Google Scholar 

  27. Guazzi M, Marenzi G, Alimento M, Contini M, Agostoni P. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997;95:1930–1936.

    Google Scholar 

  28. Riegger GA, Kahles HW, Elsner D, Kromer EP, Kochsiek K. Effects of acetylsalicylic acid on renal function in patients with chronic heart failure. Am J Med 1991;90(5):571–575.

    Google Scholar 

  29. Schwartz D, Kornowski R, Lehrman H, Averbuch M, Pines A, Greenland M, Finkelstein A, Levo Y. Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure. Cardiology 1992;81(6):334–339.

    Google Scholar 

  30. Nguyen KN, Aursnes I, Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II. Am J Cardiol 1997;79(2):115–119.

    Google Scholar 

  31. Peterson JG, Topol EJ, Sapp SK, Young JB, Lincoff AM, Lauer MS. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease. Am J Med 2000;109:371–377.

    Google Scholar 

  32. Latini R, Tognoni G, Maggioni AP, Baigent C, Braunwald E, Chen ZM, Collins R, Flather M, Franzosi MG, Kjekshus J, Kober L, Liu LS, Peto R, Pfeffer M, Pizzetti F, Santoro E, Sleight P, Swedberg K, Tavazzi L, Wang W, Yusuf S. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol 2000;35(7):1801–1807.

    Google Scholar 

  33. Oosterga M, Anthonio RL, de Kam PJ, Kingma JH, Crijns HJ, van Gilst WH. Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction. Am J Cardiol 1998;81(10):1178–1181.

    Google Scholar 

  34. Latini R, Santoro E, Masson S, Tavazzi L, Maggioni AP, Franzosi M, Barlera S, Calvillo L, Salio M, Staszewsky L, Labarta V, Tagnoni G. For the GISSI-3 Investigators. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction. Results of the GISSI-3 Trial. Heart Disease 2000;2:185–190.

    Google Scholar 

  35. Leor J, Reicher-Reiss H, Goldbourt U, Boyko V, Gottlieb S, Battler A, Behar S. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol 1999;33(7):1920–1925.

    Google Scholar 

  36. Parmley WW. Pathophysiology of congestive heart failure. Am J Cardiol 1985;56(2):7A–11A.

    Google Scholar 

  37. Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. J Am Coll Cardiol 1998;31(2):419–425.

    Google Scholar 

  38. Chen Y, Radford MJ, Krumhoz. Aspirin and the treatment of heart failure in the elderly. J Am Coll Cardiol 2000;35(2):(suppl. A) P. 541.

    Google Scholar 

  39. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald E, for the ACE-inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systemic overview of data from individual patients. Lancet 2000;355:1575–1581.

    Google Scholar 

  40. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol 1999;83(2A):1A–38A

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Aviv University, Tel-Hashomer, Israel

    Israel M. Barbash, Shmuel Gottlieb, Uri Goldbourt, Solomon Behar & Jonathan Leor

Authors
  1. Israel M. Barbash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shmuel Gottlieb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uri Goldbourt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Solomon Behar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jonathan Leor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barbash, I.M., Gottlieb, S., Goldbourt, U. et al. Aspirin and ACE-inhibitors: for Wedding or Funeral?. J Thromb Thrombolysis 11, 163–169 (2001). https://doi.org/10.1023/A:1011232918173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011232918173

Keywords

Search

Navigation